Triple
T33292185
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Andexxa |
E852344
|
entity |
| Predicate | hasPharmacologicTarget |
P37016
|
FINISHED |
| Object | factor Xa inhibitors |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: factor Xa inhibitors | Statement: [Andexxa, hasPharmacologicTarget, factor Xa inhibitors]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: hasPharmacologicTarget Context triple: [Andexxa, hasPharmacologicTarget, factor Xa inhibitors]
-
A.
hasMolecularTarget
chosen
Indicates that one entity (such as a drug or compound) is directed toward, binds to, or specifically interacts with a particular molecular target (such as a protein, receptor, or gene).
-
B.
isTherapeuticTargetIn
Indicates that a biological entity (e.g., gene, protein, pathway) is used or proposed as a therapeutic target within a specified disease, condition, or treatment context.
-
C.
hasPharmacologicalEffect
Indicates that one entity produces a specific pharmacological effect or action on another entity.
-
D.
hasDrugBankID
Indicates that an entity is associated with a specific identifier from the DrugBank database.
-
E.
targetsProtein
Indicates that one entity is directed toward, binds to, or is intended to affect a specific protein as its primary molecular target.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69f349660ff48190a4568803d0b89941 |
completed | April 30, 2026, 12:21 p.m. |
| NER | Named-entity recognition | batch_69f7431c0eec81909ead443e07d75e18 |
completed | May 3, 2026, 12:44 p.m. |
| PD | Predicate disambiguation | batch_69f74143cf708190a12d487884298437 |
completed | May 3, 2026, 12:36 p.m. |
Created at: May 1, 2026, 1:32 a.m.